On March 21, the British Gov. web announced that three procurement contracts for COVID-19 antigen reagents. Orient Gene, ACON Biotech and Getein Biotech indirectly won the contracts of £ 595 million, £ 237.8 million and £ 85 million respectively. The three contracts start on February 23 and the deadline is August 20.
The 3 companies of TANNER PHARMA UK LIMITED, MEDCO SOLUTIONS LTD & PHARMACEUTICALS DIRECT LIMITED won the contracts of antigen reagents announced by British Gov. with values of £ 595 million, £ 237.8 million and £ 85 million respectively. Orient Gene shares 65% on the total value of £ 917.8 million.
£ 917.8 million equals to 7.7 billion CNY.
The signed contract with TANNER PHARMA UK LIMITED is about 5 billion CNY, which is to supply the COVID-19 antigen self-test reagent to Health and Safety Executive (HSE) by Orient Gene. 2 billion CNY contract signed by MEDCO SOLUTIONS LTD & ACON Biotech is to supply the COVID-19 antigen self-test reagent to HSE. And Getein Biotech signed the contract with PHARMACEUTICALS DIRECT LIMITED.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.